Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance - Wikidata - awgldk - TriplyDB

Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance

Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance

http://www.wikidata.org/entity/Q37011167

about

Oral substitution treatment of injecting opioid users for prevention of HIV infection HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi'an, China Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.Substance use and hepatitis C: an ecological momentary assessment study.Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.Physicians' attitudes towards office-based delivery of methadone maintenance therapy: results from a cross-sectional survey of Nova Scotia primary-care physicians.The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review.Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.Substance Use Patterns of HIV-Infected Russian Women with and Without Hepatitis C Virus Co-infection.Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan.

P2860

Q24234956-5CF46913-C792-42A6-8C54-4623A8A11128 Q28483942-E2872955-0B9D-4144-A677-EE83CF8D2213 Q34864661-C84FF5A2-95BF-4E89-AE07-347A68C23286 Q36027332-37A605DD-9B6E-42EA-94AA-550F2A1E95E3 Q36073120-9F348DE7-0DEE-4073-B31F-298B8A331088 Q36137709-301849FB-D7B1-4782-BB5B-400739541D56 Q36241476-F251D7CB-05FC-4F09-88BF-AE486767C5C2 Q36775905-2523C29D-EEE3-46D3-98BF-50B369615BAD Q37039976-ABD7BAED-96E9-4E70-B9E0-A6E656164ACA Q39918668-E82900FA-706C-4471-9481-79C6F205734D Q40748586-E8D6ACF0-E117-4B4F-9CB7-FA351CDA028B Q41987974-DAA0EA3F-31E2-4FE9-91CC-1D01368FA20F

P2860

Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance

http://www.wikidata.org/entity/Q37011167

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 October 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatitis C and human immunode ...... users on methadone maintenance

@en

Hepatitis C and human immunode ...... sers on methadone maintenance.

@nl

type

label

Hepatitis C and human immunode ...... users on methadone maintenance

@en

Hepatitis C and human immunode ...... sers on methadone maintenance.

@nl

prefLabel

Hepatitis C and human immunode ...... users on methadone maintenance

@en

Hepatitis C and human immunode ...... sers on methadone maintenance.

@nl

P1433

Q37011167-88D751A2-E29C-4B00-8B5E-C14D2BB5378D

P1476

Q37011167-B503CFC8-482B-4AF8-A7E7-E2EEF060CD80

P2093

Q37011167-08B682AC-CF8F-42A1-A912-E33EBA1A0D40

Q37011167-35424B99-1AFD-43A7-AE35-284698A27172

Q37011167-7A058822-994A-496F-8727-B3FA7E21951C

Q37011167-8E326FC6-5F72-4699-894E-3E5B45F32DD2

Q37011167-9195A338-D6F1-4E01-8F84-4DB212FA971F

P2860

Q37011167-01425F14-1880-47CB-949E-075D4C60FA98

Q37011167-022D3D0B-2765-468A-948D-CC0172AB0E8C

Q37011167-074617D1-2BB1-4A0D-B47F-C546391FF2B4

Q37011167-19E98EC5-A35C-44CF-B266-0743162B842D

Q37011167-1EF87696-084D-4048-B7F0-513708BFC9E4

Q37011167-2705C052-B509-4E66-A3CB-178861941CF0

Q37011167-2C5A8920-BE6B-47BF-B45E-396DAB81DA20

Q37011167-35CB6D7B-020F-4911-9C42-0D607741885A

Q37011167-3DD398E5-72CB-471E-ACAF-64C0564C47C9

Q37011167-3E409A16-5777-46F8-B622-DD1CF14D72F3

P304

Q37011167-2646C03D-032B-4F56-A041-D683A61DBCB4

P31

Q37011167-74575AE4-E4BE-43F3-ABAD-D8709F742B3A

P356

Q37011167-FD1277AA-B974-43E4-8FCD-23E5802468A7

P433

Q37011167-9E69170C-BE3F-4264-9080-EAD200D830EA

P478

Q37011167-CDD7F5D4-0FD4-41F0-8C52-D95D56810445

P577

Q37011167-B5A4DD2C-A17B-49AD-B932-E2A44B9A490A

P5875

Q37011167-ECBBB948-13FA-4EED-9A04-93D3BFA0AFF1

P698

Q37011167-EE4B9A7D-F666-4C7C-8007-AA940502D362

P932

Q37011167-14E0B88A-AF3E-47E7-8919-7FBBE05932F6

P356

J.JSAT.2007.08.011

P1433

Journal of Substance Abuse Treatment

P1476

Hepatitis C and human immunode ...... users on methadone maintenance

@en

P2093

David H Epstein

http://www.w3.org/2001/XMLSchema#string

Jessica Willner-Reid

http://www.w3.org/2001/XMLSchema#string

John Schmittner

http://www.w3.org/2001/XMLSchema#string

Katherine A Belendiuk

http://www.w3.org/2001/XMLSchema#string

Kenzie L Preston

http://www.w3.org/2001/XMLSchema#string

P2860

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

Self-reported hepatitis C virus antibody status and risk behavior in young injectors

The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men

A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.

Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.

Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

P304

78-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSAT.2007.08.011

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5913065

http://www.w3.org/2001/XMLSchema#string

P698

17931826

http://www.w3.org/2001/XMLSchema#string

P932

2600879

http://www.w3.org/2001/XMLSchema#string